Key facts
- It has raised $110K; the latest was Angel (individual) ($110K) in Aug 2025.
- Notable investors include IIT Madras Incubation Cell.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for ISMO Bio-Photonics
- ·The full record, as it builds
Funding rounds
No funding rounds for ISMO Bio-Photonics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ISMO Bio-Photonics
Developer of personalized organ-on-chip technology designed for the purpose of advancing tailored therapeutics in healthcare. The company's platform integrates bio-photonic engineering with microfluidic systems to replicate human organ functions, conduct precise drug testing, disease modeling, and therapeutic development through customizable, physiologically relevant models, enabling pharmaceutical researchers, clinicians, and healthcare innovators to support improved prediction of human responses and facilitate the creation of effective, patient-specific treatments.
- Sector
- Healthcare
- HQ
- Chennai, India
- Founded
- 2020
- Website
- ismobiophotonics.com/
- Ownership
- Privately Held (backing)
ISMO Bio-Photonics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ISMO Bio-Photonics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ISMO Bio-Photonics in its N-PORT filings yet. We sweep new filings monthly.